Johnson & Johnson is gearing up to deliver 20 million doses of its new coronavirus vaccine to the U.S. government by the end of March and is “confident” of being able to supply 100 million of the single-dose shots during the first half of 2021, a company official is expected to testify to a House subcommittee Tuesday.